Primary record
1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium
- 库存
- 7,193 克
- 纯度
- 98.2 %
- CAS
- 53-84-9
化合物标识与属性
- CAS
- 53-84-9
- PubChem CID
- 5892
- SMILES
- C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N
- Canonical SMILES
- NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1
名称与同义词
- nadide
- coenzyme I
- NAD+
- beta-NAD
- Codehydrase I
- Codehydrogenase I
- Cozymase I
- Enzopride
- Nadidum
- codehydrogenase
- Nadida
- beta-NAD+
- diphosphopyridine nucleotide
- nicotinamide adenine dinucleotide
- COZYMASE
- beta-nicotinamide adenine dinucleotide
- NAD zwitterion
- 53-84-9
- NAD Lithium salt
- beta-Diphosphopyridine nucleotide
- nadid
- null
- Endopride
- CO-I
- Coenzyme 1
- NADLithiumsalt
- Nicotinamide dinucleotide
- beta-DPN
- betaNAD+
- NAD trihydrate
- Nadidum [INN-Latin]
- NAD+, Free Acid
- betaNAD
- .beta.-NAD
- NAD-oxidized
- Nadida [INN-Spanish]
- Nicotinamide-adenine dinucleotide
- |A-nad
- nicotinamide adenine
- Viatrexx-NAD Plus
- Co I
- DPN-ox
- NAD+ (Standard)
- Pyridine, nucleotide diphosphate
- Adenine-nicotinamide dinucleotide
- CO-1
- Nicotineamide adenine dinucleotide
- NADIDUM [HPUS]
- NADIDE [USAN]
- NADIDE [INN]
- NADIDE [JAN]
- Oxidized diphosphopyridine nucleotide
- NADIDE [WHO-DD]
- Nadidum (INN-Latin)
- NADIDE [MART.]
- Nadida (INN-Spanish)
- C-NAD
- Nadide [USAN:INN:BAN:JAN]
- DPN+
- beta-Diphosphopyridinenucleotide
- RefChem:831676
- 0U46U6E8UK
- 3-carbamoylpyridin-1-ium
- NAD(SUP +)
- UNII-0U46U6E8UK
- NADIDE (MART.)
- [adenylate-32-P]-NAD
- Carbonyl [14C] NAD+
- D0M3KZ
- AC1L1LD0
- NAD [MI]
- NAD, Grade I, free acid
- EINECS 200-184-4
- ?-NAD
- [adenylate-32-P]-NAD+
- |A-DPN LITHIUM SALT
- NAD, Grade II, free acid
- NSC 20272
- C21H27N7O14P2
- DTXSID2045236
- Nicotinamide Adinine Dinucleotide
- Nicotinamide-Adenine-Dinucleotide
- SCHEMBL131544
- SPECTRUM1500419
- NAD
- Pyridine nucleotide diphosphate
- Adeninenicotinamide dinucleotide
- BAWFJGJZGIEFAR-NNYOXOHSSA-N
- betaDiphosphopyridine nucleotide
- BRN 3584133
- MFCD00036253
- Nicotinamideadenine dinucleotide
- NSC-20272
- GTPL2451
- NAD(+)
- ?-Nicotinamide adenine dinucleotide
- NICOTINAMIDE ADENINE 1GM
- NICOTINAMIDE ADENINE 1KG
- NICOTINAMIDE ADENINE 5GM
- CHEMBL1234613
- DTXCID0025236
- Nadide [USAN:BAN:INN:JAN]
- SCHEMBL29351635
- SCHEMBL29353727
- |A-Nicotinamide adenine dinucleotide
- CHEBI:44215
- CTK8B3792
- diphosphopyridine nucleotide oxidized
- ERK5-1H12
- HMS500J11
- HY-B0445R
- CID5892
- NICOTINAMIDE ADENINE 25GM
- [14C] NAD+
- [32P] NAD+
- BDBM213227
- GLXC-10877
- HMS2091H06
- HMS2097E04
- HMS3714E04
- nicotinamide adenine dinucleotide oxidized
- Pharmakon1600-01500419
- NICOTINAMIDE ADENINE 100GM
- EX-A3535
- HY-B0445
- NSC20272
- betaNicotinamide adenine dinucleotide
- Diphosphopyridine nucleotide (DPN+)
- Nicotinamide adenine dinucleotide (NAD)
- Thionicotinamide adenine dinucleotide
- Tox21_110321
- 3-acetylpyridine adenine dinucleotide
- 6614AF
- ANW-43201
- CCG-40114
- MSK000609
- NSC757121
- s2518
- bera-Nicotinamide adenine dinucleotide
- AKOS015892319
- beta-nicotinamide adenine din-ucleotide
- ACN-053290
- CM11026
- CS-2554
- DB14128
- EBC-616214
- NN11969
- NSC-757121
- .beta.-Nicotinamide adenine dinucleotide
- CAS-53-84-9
- EC 200-184-4
- C21-H27-N7-O14-P2
- NCGC00016240-01
- NCGC00178839-01
- NCGC00178839-02
- NCGC00178839-03
- NCGC00178839-08
- |A-DPN; |A-NAD; Coenzyme 1; Nadide
- 5-26-16-00399 (Beilstein Handbook Reference)
- AC-37031
- AS-14652
- beta-Nicotinamide adenine dinucleotide hydrate
- BP-58726
- M041
- SBI-0051451.P003
- AB2000620
- beta-Nicotinamide adenine dinucleotide(NAD)
- J136.554A
- LS-132322
- TR-019029
- |A-Nicotinamide Adenine Dinucleotide Hydrate
- AB00513910
- D0919
- FT-0622904
- NS00100300
- -DPN;-NAD;-Nicotinamide Adenine Dinucleotide
- DPN
- A11563
- A11679
- beta-Nicotinamide adenine dinucleotide, reduced
- NICOTINAMIDE ADENINE DINUCLEOTIDE [INCI]
- AB00052048_03
- beta-Nicotinamide adenine dinucleotide trihydrate
- A927980
- b-Nicotinamide adenine dinucleotide hydrate (NAD)
- 3-Carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide, 5'-ester with adenosine 5'-pyrophosphate, inner salt
- 64417-72-7
- I02-6267
- Nicotinamide adenine dinucleotideNAD+mono sodium salt
- beta-Nicotinamide adenine dinucleotide hydrate, >=99%
- beta-Nicotinamide adenine dinucleotide, 98% - 1G 1g
- Q12499775
- |A-Nicotinamide adenine dinucleotide pound NAD pound(c)
- 1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium
- Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium hydroxide, inner salt
- F45C0D6C-DA87-47BE-9975-7A5DE9CCB985
- B0084-094034
- Adenosine 5'-(trihydrogen diphosphate), 5'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, hydroxide, inner salt
- beta-Nicotinamide adenine dinucleotide hydrate, >=95% (HPLC)
- Pyridinium, 3-carbamoyl-1-beta-D-ribofuranosyl-, hydroxide, 5'-ester with adenosine 5'-5'-(trihydrogen pyrophosphate), inner salt
- beta-Nicotinamide adenine dinucleotide, pkg of 10 mg (per vial)
- beta-Nicotinamide adenine dinucleotide, pkg of 20 mg (per vial)
- beta-Nicotinamide adenine dinucleotide, pkg of 50 mg (per vial)
- (5S)-5-[(4-HYDROXYPHENYL)METHYL]-2,2-DIMETHYL-1,3-DIOXOLAN-4-ONE
- [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate
- 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1lambda5-pyridin-1-ylium
- 3-CARBAMOYL-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM HYDROXIDE 5'->5'-ESTER WITH ADENOSINE 5'-(TRIHYDROGEN PYROPHOSPHATE) INNER SALT
- 3-CARBAMOYL-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM HYDROXIDE, 5'-ESTER WITH ADENOSINE 5'-PYROPHOSPHATE, INNER SALT
- 4090-29-3
- ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE) P'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM INNER SALT
- ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE), 5'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM, HYDROXIDE, INNER SALT
- Adenosine 5'-(trihydrogen diphosphate), P'->5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt
- Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt
- Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 3-(aminocarbonyl)-1-.beta.-D-ribofuranosylpyridinium, inner salt
- Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt
- beta-Nicotinamide adenine dinucleotide hydrate, >=98%, BioUltra, from yeast
- beta-Nicotinamide adenine dinucleotide hydrate, Grade AA-1, >=95% (HPLC)
- Nicotinamide Adenine Dinucleotide 95% (Nad, Dpn) for biochemistry 100mg
- 3-Carbamoyl-1-D-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate
- beta-Nicotinamide adenine dinucleotide hydrate, purified by column chromatography, >=99%
- beta-Nicotinamide adenine dinucleotide hydrate, Vetec(TM) reagent grade, >=96.5%
- (((2R,3S,4R,5R)-5-(6-amino-7H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-oxidophosphoryl) ((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl phosphate
- (((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-hydroxyphosphoryl) ((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl hydrogen phosphate
- (((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-oxidophosphoryl) ((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl phosphate;hydron
- ((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl (((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-hydroxyphosphoryl) phosphate
- [(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate
- [(3S,2R,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3S,2R,4R,5R)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl) hydrogen phosphate
- [(3S,2R,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3S,2R,4R,5R)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl)hydrogen phosphate
- [[(2R,3S,4R,5R)-5-(6-amino-7H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate
- [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate
- [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate
- [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate;hydron
- 1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-
- 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1-pyridin-1-ylium
- 200-184-4
- 3-(Aminocarbonyl)-1-[5-O-[(5 -adenylyloxy)oxylatophosphinyl]-beta-D-ribofuranosyl]pyridinium
- 3-(Aminocarbonyl)-1-[5-O-[[1-(6-amino-9H-purin-9-yl)-1-deoxy-beta-D-ribofuranose-5-O-yl]phosphonyloxy(oxylato)phosphinyl]-beta-D-ribofuranosyl]pyridinium
- 3-CARBAMOYL-1-BETA-D-RIBOFURANOSYLPYRIDINIUM HYDROXIDE 5'->5'-ESTER WITH ADENOSINE 5'-(TRIHYDROGEN PYROPHOSPHATE) INNER SALT
- 3-Carbamoyl-1-Beta-D-Ribofuranosylpyridinium Hydroxide 5'-5'-Ester with Adenosine 5'-(Trihydrogen Pyrophosphate) Inner Salt
- 3-Carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate inner salt
- 3-Carbamoyl-1-beta-delta-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate inner salt
- 3-Carbamoyl-1-delta-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate
- 3Carbamoyl1betaDribofuranosylpyridinium hydroxide, 5'ester with adenosine 5'pyrophosphate, inner salt
- 477981-33-2
- A3D
- Adenosine 5'(trihydrogen diphosphate), 5'5'ester with 3(aminocarbonyl)1betaDribofuranosylpyridinium, hydroxide, inner salt
- Adenosine 5'(trihydrogen diphosphate), P'.fwdarw.5'ester with 3(aminocarbonyl)1betaDribofuranosylpyridinium, inner salt
- Adenosine 5'(trihydrogen diphosphate), P'>5'ester with 3(aminocarbonyl)1betaDribofuranosylpyridinium, inner salt
- Adenosine 5'(trihydrogen diphosphate), P'5'ester with 3(aminocarbonyl)1betaDribofuranosylpyridinium hydroxide, inner salt
- Adenosine 5'(trihydrogen diphosphate), P'5'ester with 3(aminocarbonyl)1betaDribofuranosylpyridinium, inner salt
- ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE) P'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-BETA-D-RIBOFURANOSYLPYRIDINIUM INNER SALT
- ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE), 5'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-BETA-D-RIBOFURANOSYLPYRIDINIUM, HYDROXIDE, INNER SALT
- Adenosine 5'-(trihydrogen diphosphate), 5'.fwdarw.5'-ester with 3-(aminocarbonyl)-1-.beta.-D-ribofuranosylpyridinium hydroxide, inner salt
- Adenosine 5'-(trihydrogen diphosphate), P'-->5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt
- Adenosine 5'-(trihydrogen diphosphate), P'?5'-ester with 3-(aminocarbonyl)-1-.beta.-D-ribofuranosylpyridinium, inner salt
- Adenosine 5'-(trihydrogen diphosphate-P-32P), P'>5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt (9CI)
- beta-Nicotinamide adenine dinucleotide hydrate, >=96.5% (HPLC), >=96.5% (spectrophotometric assay), from yeast
- beta-Nicotinamide adenine dinucleotide hydrate, cell culture tested, >=96.5% (HPLC), >=96.5% (spectrophotometric assay), from yeast
- NAH
- Pyridinium, 3-carbamoyl-1-b-D-ribofuranosyl-, hydroxide, 5'-5'-ester with adenosine 5'-(trihydrogen pyrophosphate), inner salt (8CI)
- Pyridinium, 3carbamoyl1betaDribofuranosyl, hydroxide, 5'ester with adenosine 5'5'(trihydrogen pyrophosphate), inner salt
- ss-Nicotinamide adenine dinucleotide, oxidized form (NAD, oxidized form) trihydrate =95% for biochemistry